Taiwan Otsuka Pharmaceutical
ent_ba284bc5577ceed19c6eb6dd
Disclosures
2
Leak Site · 1 jurisdiction
Multi-filing incidents
—
no multi-filing incident in sample
Max affected reported
—
no filed count in sample
Leak-site claims
2
unverified actor claims
Identity resolution
- Canonical name
- Taiwan Otsuka Pharmaceutical
- Normalized
- taiwan otsuka pharmaceutical— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- No match
- SEC EDGAR CIK
- None — not an SEC registrant
- Domain
- otsuka.com.tw
Unverified threat-actor claim — not a regulatory filing
Attribution, victim identity, and counts shown here derive from a threat actor's public extortion-blog claims, aggregated by ransomware.live. They have not been validated by the victim or any regulator. Treat them as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Disclosure history (2)newest first
- GLOBALLeak Siteas victim2026-10-14
otsuka.com.tw Revenue $278.3 Million Otsuka Pharmaceutical (Taiwan) Co., Ltd. Taiwanese arm of Japan's Otsuka Holdings (TSE: 4578), operating since 1974 — first as a JV, wholly owned since 1995. HQ in Taipei's Daan District with plants in Guandu and Kaohsiung, ~500–1,000 staff, capital NT$531M, president Ryoichi Fukumoto. Core business: prescription drugs (Abilify, Mucosta, nephrology/oncology lines), consumer brands (Pocari Sweat, Nature Made, CalorieMate, SOYJOY), medical devices, and a new insurance services arm. The group posted record 2025 pharma results (+22% revenue, +43% operating profit) across 84+ countries. Taiwan-specific financials aren't published (subsidiary of a listed parent), but the entity has 52 years on the market, TFDA-registered products, and a solid employer brand with active hiring since 2024.
- GLOBALLeak Siteas victim2026-10-14
Taiwan Otsuka Pharmaceutical was founded in 1974, with the philosophy of "pursuing the health and well-being of people worldwide". With the continuous efforts for the expansion and renewal of production equipment, pharmaceutical technology has continuously improved the quality. It has driven Taiwan's pharmaceutical industry to recognize the high-quality infusion containers. Taiwan Otsuka Pharmaceutical Factory was ranked as Grade A by the Department of Health in 1984. It was approved as a GMP pharmaceutical factory by the Department of Health and the Ministry of Economic Affairs of the Executive Yuan in 1986. It was approved as a PIC/S GMP pharmaceutical factory by the Department of Health of the Executive Yuan in 2010, and its products are exported to many countries in Asia, which proves that the quality has reached the high standard. Taiwan Otsuka Pharmaceutical also adheres to the business philosophy of "Otsuka people" and is committed to research and development. We will continue to strive for perfection and make unremitting efforts for the health of the people and the well-being of the society. At the same time, we hope that all sectors of society will continue to give us advice and guidance. We will also adhere to the spirit of "honesty, creativity, and service" to achieve our goals.